Our website uses cookies to improve and personalize your experience. Our website may also include cookies from third parties like Google Adsense, Google Analytics, YouTube. By using this website, you consent to the use of cookies. We've updated our Privacy Policy, please click on the button beside to check our Privacy Policy.

International Cancer Institute

Cancer Care, Research Training & Education

Home ICI Clinical Trials

Clinical Trials at International Cancer Institute (ICI)

 

 

As part of our mission to eliminate cancer in Sub-Saharan Africa, International Cancer Institute’s clinicians and researchers conduct a number of clinical trials to effectively treat both cancer and blood diseases including sickle cell disease, haemophilia, and other bleeding disorders. 

 

Any time you or a loved one needs treatment for cancer, clinical trials are an option to think about. Learning all about them can help you talk with your doctor and decide what is right for you. We will continue to update the list of clinical trials available below for which you may be eligible.

The International Cancer Institute Centre for Data, Training and Research engage in clinical trials to find better ways to prevent, diagnose and treat cancer and other non-communicable diseases. 

 

Clinical trials are a type of research studies that patients may volunteer to take part to evaluate new and possibly beneficial treatments, procedures, devices, and elements of care. Doctors and other health care professionals use treatment trials to learn more about how to fight diseases and advance modern medicine. This guide is for patients who may join a treatment trial. 

 

Treatment trials are part of a long, careful process, which may take many years. First, doctors study a new treatment in the lab. They then often study the treatment in animals. If a new treatment shows promise, doctors then test the treatment in people to evaluate their effectiveness on health outcomes and consequently decide their implementation to standards of care. Doctors do this in three-four phases using cohorts of different population sizes to evaluate drug effectiveness, dosage, toxicity, side effects/adverse effects, and other responses. 

 

Your doctor at ICI may offer you a clinical trial as a treatment option. 

ICI’s most important job is to protect patients. First, we enrol patients in clinical trials by following well-planned protocols. 

 

A protocol:

 

  • Explains the treatment plan
  • Lists the medical tests patients will receive
  • Gives the number of how many patients that will take part in the clinical trial
  • Lists eligibility criteria, which are guidelines to decide who may join the clinical trial
  • Explains safety information

 

Second, we protect patients by using a careful informed consent process.

 

Thirdly, our Institutional Review Boards (IRBs) protect patients by reviewing protocols and monitoring trials. The IRBs are committees of doctors, nurses, chaplains, social workers, lawyers, and patients. They make sure that trials follow applicable Kenyan laws and International Laws and Regulations to protect patients.

 

ICI works closely with KEMRI SERU, KPPB, NACOSTI, and the sponsors of the Clinical Trials to ensure safety, compliance, and adherence to the International Conduct of Clinical Trials.

A new treatment goes through several phases. Each phase has a different purpose. In general:

 

  • Phase I trials test if a new treatment is safe and look for the best way to give the treatment. Doctors also look for signs of the cancer responding to the new treatment.
  • Phase II trials test if a type of cancer responds to the new treatment.
  • Phase III trials test if a new treatment is better than the current standard treatment.
  • Phase IV trials find more information about long-term benefits and side effects. Treatment is then marketed.

 

Most of the time, when you take part in a clinical trial, you will only be in that one phase of the study. Treatments move through the phases, but patients do not.

Current Studies for enrolment at ICI are:

Breast Cancer

ICI has multiple clinical trials for breast cancer. Women with locally advanced or metastatic disease (Stage III or Stage IV)

  1. Hormone Receptor positive/HER-2 positive
  2. Hormone Receptor negative/HER-2 positive
  3. Hormone Receptor positive/HER-2 negative

 

Check for eligibility, care plans, appointment booking or clinical trial availability by writing to info@intercancer.com with the subject title “ICI Clinical Trials” or call our centre on +254 718 473 446 (Mondays-Fridays from 8 AM – 5 PM EAT) and ask for the Clinical Trials Coordinator for more information.

Oesophageal Cancer

Those diagnosed with oesophageal cancer with stage III or stage IV. 

 

Check for eligibility, care plans, appointment booking or clinical trial availability by writing to info@intercancer.com with the subject title “ICI Clinical Trials” or call our centre on +254 718 473 446 (Mondays-Fridays from 8 AM – 5 PM EAT) and ask for the Clinical Trials Coordinator for more information.

Other solid tumours

At ICI, we provide Clinical Care, Treatment, and follow-ups in a multi-disciplinary team approach for all solid cancers including: Prostate cancer, cervical cancer, Colon cancer, Lung Cancers, Thoracic cancers, Rectal cancers, Head and Neck cancers, Sarcomas, Liver cancers, Pancreatic cancer, Gastric cancers, Genito-urinary cancers, gynaecologic cancers, and paediatric cancers.

 

Check for eligibility, care plans, appointment booking or clinical trial availability by writing to info@intercancer.com with the subject title “ICI Clinical Trials” or call our centre on +254 718 473 446 (Mondays-Fridays from 8 AM – 5 PM EAT) and ask for the Clinical Trials Coordinator for more information.

Other hematologic cancers

At ICI, we provide Clinical Care, Treatments, and follow-ups in a multi-disciplinary team approach for all haematological conditions: including Multiple Myeloma, Plasmacytoma, Myelodysplastic syndromes (MDS), Myeloproliferative disorders, Anaemia, etc.

 

Check for eligibility, care plans, appointment booking or clinical trial availability by writing to info@intercancer.com with the subject title “ICI Clinical Trials” or call our centre on +254 718 473 446 (Mondays-Fridays from 8 AM – 5 PM EAT) and ask for the Clinical Trials Coordinator for more information.

Sickle Cell Disease

ICI has multiple Sickle Cell Disease Clinical Trials. For one to be eligible to participate, you;

Must have:

  1. A diagnosis proven by haemoglobin electrophoresis
  2. Have at least 3 vaso-occlusive crisis/year that requires hospital visit/admissions or health care professional’s intervention
  3. If using hydroxyurea, must be on a stable dose for at least 6 months. 
  4. Those not on hydroxyurea are also welcome for assessment at ICI Clinical Care & Research Clinic if potential candidates for the studies.

 

Check for eligibility, care plans, appointment booking or clinical trial availability by writing to info@intercancer.com with the subject title “ICI Clinical Trials” or call our centre on +254 718 473 446 (Mondays-Fridays from 8 AM – 5 PM EAT) and ask for the Clinical Trials Coordinator for more information.

Upcoming Research Studies at ICI

 

  1. Lung Cancer
  2. Multiple Myeloma
  3. Lymphoma
  4. Prostate Cancer
  5. Liver Cancer
  6. Others

 

Check for eligibility, care plans, appointment booking or clinical trial availability by writing to info@intercancer.com with the subject title “ICI Clinical Trials” or call our centre on +254 718 473 446 (Mondays-Fridays from 8 AM – 5 PM EAT) and ask for the Clinical Trials Coordinator for more information.

Opening Hours

Monday – Friday 8.00 – 17.00
Weekends Closed
Holidays Closed

Quick Contacts

  • Address P.O. Box 8088-30100, Nandi Rd., Eldoret
  • Phone +254 718 473 446
International Cancer Institute